The White House shared a photograph of Donald Trump holding a Washington Post headline that reported the sharpest decline in prescription drug prices in more than six decades, a post that omitted the article’s attribution of the drop to Biden‑era Medicare price‑negotiation provisions. The headline, published Thursday, described a 3.1% fall in drug prices in July, the largest year‑over‑year decrease since the early 1960s, according to Consumer Price Index data released by the Bureau of Labor Statistics. The decline coincided with the first year of implementation of the Inflation Reduction Act’s Medicare drug‑price negotiation clause, which allows the government to negotiate prices for select high‑cost medications. During a staged photo opportunity on Friday, Trump approached reporters holding a printed copy of the headline and the opening paragraphs of the article, urging the press pool to record the moment. He repeatedly said, “Prescription drug prices down more than at any time over 60 years,” and asked the audience to “have it” and “tell the public,” before walking away. The White House press secretary, Karoline Leavitt, retweeted the image with the caption “POV: you bring the receipts.” White House communications director Steven Cheung posted a screenshot of the headline on X, writing “All thanks to President Trump!” without linking to the article. However, the Washington Post report noted that independent experts attributed the price decrease to the Inflation Reduction Act, a Biden administration policy enacted in 2022 that requires Medicare to negotiate drug prices. Harvard professor Richard Frank expressed doubt that Trump’s actions were responsible, stating he would “place his money” on the law rather than Trump’s initiatives. Vanderbilt health policy professor Stacie Dusetzina similarly said the law was “more likely” to explain the decline, noting that only ten drugs have been negotiated under the act but that those are commonly used and reflected in the drug price index. The article clarified that while the Trump White House “took credit for” the drop, the text indicated “independent experts said a Biden‑era policy … is more likely to be driving down costs.” The price‑reduction trend is expected to continue as more drugs enter the Medicare negotiation schedule, though the extent to which political messaging influences public perception remains unclear.